A Survey on Cannabinoid Treatment of Pediatric Epilepsy Among Neuropediatricians in Scandinavia and Germany

A Survey on Cannabinoid Treatment of Pediatric Epilepsy Among Neuropediatricians in Scandinavia and Germany

Objectives: There is an increasing interest in cannabinoid-based products for the treatment of refractory pediatric epilepsy. However, a licensed cannabidiol (CBD) product was first approved for use by the European regulatory authorities in 2019. We aimed to obtain knowledge about clinical experienc...

Full description

Bibliographic Details
Main Authors: Claus Klingenberg, George Mouslet, Helle Hjalgrim, Thorsten Gerstner
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Pediatrics
Subjects:
cannabinoid
refractory epilepsy
Dravet syndrome
Lennox-Gastaut syndrome
survey
Online Access:https://www.frontiersin.org/article/10.3389/fped.2020.00416/full

Similar Items

Similar Items